Home

Elizabeth A. Barrett

CIK 1764157 · Chief Executive Officer · last filed 2026-06-23

Elizabeth A. Barrett is a Chief Executive Officer who has filed 28 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for ALLO, was dated Jun 23, 2026. Across all open-market trades the lifetime net is +$153.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $13.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$13.36M

Companies

3

Total Filings

28

Lifetime Open-Market Net

$153.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALLO Director — $1.66 — $0 6 2026-06-23
URGN Chief Executive Officer 326,691 $40.88 $13.36M $153.4K 20 2026-02-19
Sage Therapeutics, Inc. (SAGE) Delisted Director 0 $8.68 $0 $0 2 2025-07-31

Recent Filings

28 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-23 ALLO Grant (A) — $0 EDGAR
2026-02-19 URGN Grant (A) — $0 EDGAR
2025-07-31 Sage Therapeutics, Inc. (SAGE) Delisted Mixed −3,000 $0 EDGAR
2025-07-30 URGN Grant (A) — $0 EDGAR
2025-06-23 ALLO Grant (A) — $0 EDGAR
2025-06-13 Sage Therapeutics, Inc. (SAGE) Delisted Grant (A) — $0 EDGAR
2025-02-04 URGN Grant (A) — $0 EDGAR
2024-06-07 ALLO Grant (A) — $0 EDGAR
2024-02-02 URGN Grant (A) — $0 EDGAR
2023-06-15 ALLO Grant (A) — $0 EDGAR
Showing 1–10 of 28
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.